deltatrials
Unknown PHASE2 INTERVENTIONAL NCT00006115

Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer

Alternation of FOLFOX6 (Oxaliplatin - Leucovorin - Fluorouracil) and FOLFIRI (Irinotecan - Leucovorin - Fluorouracil) as Second Line Treatment of Metastatic Colorectal Cancer

Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group

Updated 7 times since 2017 Last updated: Jan 10, 2009 Started: Apr 30, 1999
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Colorectal Cancer, this trial is ongoing. The trial is conducted by GERCOR - Multidisciplinary Oncology Cooperative Group and has accumulated 7 data snapshots since 1999. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Feb 2018 · 13 months · monthly snapshotUnknown Status~Feb 2018 – ~Jun 2018 · 4 months · monthly snapshotUnknown Status~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotUnknown~Sep 2025 – present · 8 months · monthly snapshotUnknown

Change History

7 versions recorded
  1. Sep 2025 — Present [monthly]

    Unknown PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Unknown PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE2

    Status: Unknown StatusUnknown

  4. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE2

  5. Jun 2018 — Jan 2021 [monthly]

    Unknown Status PHASE2

Show 2 earlier versions
  1. Feb 2018 — Jun 2018 [monthly]

    Unknown Status PHASE2

  2. Jan 2017 — Feb 2018 [monthly]

    Unknown Status PHASE2

    First recorded

Apr 1999

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • GERCOR - Multidisciplinary Oncology Cooperative Group
Data source: National Cancer Institute (NCI)

For direct contact, visit the study record on ClinicalTrials.gov .